These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11454539)

  • 1. Thalidomide therapy in compensated and decompensated myelofibrosis with myeloid metaplasia.
    Pozzato G; Zorat F; Nascimben F; Comar C; Kikic F; Festini G
    Haematologica; 2001 Jul; 86(7):772-3. PubMed ID: 11454539
    [No Abstract]   [Full Text] [Related]  

  • 2. Thalidomide therapy for myelofibrosis with myeloid metaplasia.
    Thomas DA; Giles FJ; Albitar M; Cortes JE; Verstovsek S; Faderl S; O'Brien SM; Garcia-Manero G; Keating MJ; Pierce S; Zeldis J; Kantarjian HM
    Cancer; 2006 May; 106(9):1974-84. PubMed ID: 16583431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis and anti-angiogenic therapy in myelofibrosis with myeloid metaplasia.
    Arora B; Mesa R; Tefferi A
    Leuk Lymphoma; 2004 Dec; 45(12):2373-86. PubMed ID: 15621750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical efficacy and antiangiogenic activity of thalidomide in myelofibrosis with myeloid metaplasia. A pilot study.
    Piccaluga PP; Visani G; Pileri SA; Ascani S; Grafone T; Isidori A; Malagola M; Finelli C; Martinelli G; Ricci P; Baccarani M; Tura S
    Leukemia; 2002 Sep; 16(9):1609-14. PubMed ID: 12200671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mini-dose of thalidomide for treatment of primary myelofibrosis. Report of a case with complete reversal of bone marrow fibrosis and splenomegaly.
    Berrebi A; Feldberg E; Spivak I; Shvidel L
    Haematologica; 2007 Feb; 92(2):e15-6. PubMed ID: 17405746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow angiogenesis and its clinical correlates in myelofibrosis with myeloid metaplasia.
    Arora B; Ho CL; Hoyer JD; Mesa RA; Tefferi A
    Haematologica; 2004 Dec; 89(12):1454-8. PubMed ID: 15590395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thalidomide versus placebo in myeloid metaplasia with myelofibrosis: a prospective, randomized, double-blind, multicenter study.
    Abgrall JF; Guibaud I; Bastie JN; Flesch M; Rossi JF; Lacotte-Thierry L; Boyer F; Casassus P; Slama B; Berthou C; Rodon P; Leporrier M; Villemagne B; Himberlin C; Ghomari K; Larosa F; Rollot F; Dugay J; Allard C; Maigre M; Isnard F; Zerbib R; Cauvin JM;
    Haematologica; 2006 Aug; 91(8):1027-32. PubMed ID: 16885042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thalidomide use and digital gangrene.
    Kang TY; Lowe CJ; Sekeres MA
    J Clin Oncol; 2006 Nov; 24(33):5328. PubMed ID: 17114666
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment considerations for primary myelofibrosis.
    Biemond BJ
    Neth J Med; 2010 Aug; 68(1):291-2. PubMed ID: 20739724
    [No Abstract]   [Full Text] [Related]  

  • 10. A phase 2 trial of combination low-dose thalidomide and prednisone for the treatment of myelofibrosis with myeloid metaplasia.
    Mesa RA; Steensma DP; Pardanani A; Li CY; Elliott M; Kaufmann SH; Wiseman G; Gray LA; Schroeder G; Reeder T; Zeldis JB; Tefferi A
    Blood; 2003 Apr; 101(7):2534-41. PubMed ID: 12517815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serious myeloproliferative reactions associated with the use of thalidomide in myelofibrosis with myeloid metaplasia.
    Tefferi A; Elliot MA
    Blood; 2000 Dec; 96(12):4007. PubMed ID: 11186278
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide: no benefit in myelofibrosis with myeloid metaplasia.
    Bonn D
    Lancet Oncol; 2003 Feb; 4(2):70. PubMed ID: 12573345
    [No Abstract]   [Full Text] [Related]  

  • 13. Myelofibrosis with myeloid metaplasia with fatty bone marrow: report of a new case.
    Gerli GC; Gianelli U; Carraro MC; Bestetti A; Marchetti M; Barosi G
    Haematologica; 2001 Aug; 86(8):885-6. PubMed ID: 11524257
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment approaches in myelofibrosis with myeloid metaplasia: the old and the new.
    Tefferi A
    Semin Hematol; 2003 Jan; 40(1 Suppl 1):18-21. PubMed ID: 12682877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early changes in bone marrow morphology induced by thalidomide in refractory myeloma patients.
    Corso A; Lorenzi A; Zappasodi P; Invernizzi R; Vanelli L; Lazzarino M
    Haematologica; 2003 Aug; 88(8):958-60. PubMed ID: 12935985
    [No Abstract]   [Full Text] [Related]  

  • 16. Combined treatment with thalidomide, corticosteroids, and erythropoietin in patients with idiopathic myelofibrosis.
    Benetatos L; Chaidos A; Alymara V; Vassou A; Bourantas KL
    Eur J Haematol; 2005 Mar; 74(3):273-4. PubMed ID: 15693801
    [No Abstract]   [Full Text] [Related]  

  • 17. Prospective study of combination therapy with low-dose thalidomide plus prednisolone ameliorating cytopenia in primary myelofibrosis.
    Hattori Y; Miyakawa Y; Yokoyama K; Yamada T; Du W; Jinzaki M; Shinmoto H; Okamoto S
    Int J Hematol; 2011 Jan; 93(1):129-31. PubMed ID: 21153775
    [No Abstract]   [Full Text] [Related]  

  • 18. [Myelofibrosis in patients with chronic myeloid leukemia treated with interferon-alpha].
    Kumas Sotiris ; Semenova EA; Turkina AG; Zakharova AV; Domracheva EV; Khoroshko ND; Frank GA
    Arkh Patol; 2003; 65(4):9-12. PubMed ID: 14518186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thalidomide treatment in a myelofibrosis patient with leukemia transformation.
    Huang WH; Li MS; Chu SC; Wang TF; Kao RH; Wu YF
    Int J Hematol; 2014 Feb; 99(2):188-92. PubMed ID: 24307514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose thalidomide ameliorates cytopenias and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II trial.
    Marchetti M; Barosi G; Balestri F; Viarengo G; Gentili S; Barulli S; Demory JL; Ilariucci F; Volpe A; Bordessoule D; Grossi A; Le Bousse-Kerdiles MC; Caenazzo A; Pecci A; Falcone A; Broccia G; Bendotti C; Bauduer F; Buccisano F; Dupriez B
    J Clin Oncol; 2004 Feb; 22(3):424-31. PubMed ID: 14752066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.